Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Goal-directed Hemodynamic Therapy Based on Stroke Volume, Pulse Pressure Variation and Continuosus Cardiac Index in Patiens Undergoing Major Hepatic Resection

NCT04517409 is registered in ClinicalTrials.gov with Castilla-La Mancha Health Service as lead sponsor.

NCT NCT04517409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04517409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Goal-directed Hemodynamic Therapy Based on Stroke Volume, Pulse Pressure Variation and Continuosus Cardiac Index in Patiens Undergoing Major Hepatic Resection
Lead sponsor
Castilla-La Mancha Health Service
Phase
Not applicable
Overall status
Completed
Start date
November 5, 2015
Completion date
November 5, 2017
Enrollment
45 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic monitoring